Delivery Order SPE2DB22D3501-SPE2DB25FUF61
Award Date
1/21/25
Potential Completion Date
1/22/25
Potential Value
$8.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,863.65, is for the delivery of AMOX-CLAV 875-125 MG TABLET 20S, a type of antibiotic medication. The contract has a firm fixed price pricing type and a period of performance through February 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,634.87, is for the delivery of AMOX-CLAV ER 1,000-62.5 MG TAB medical supplies. There is no set-aside designation for this award. The delivery order supports DLA Troop Support Medical, which provides pharmaceutical and medical products to military treatment facilities, veterans'...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of AMOX-CLAV 875-125 MG TABLET 20S. The contract has a ceiling value of $7,526.60 and a completion date of April 25, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $2,151.66 order is for the supply of AMOX-CLAV ER 1,000-62.5 MG TAB pharmaceutical products, with a completion date of February 29, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this award, which is part of a larger indefinite delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,517.51, is a delivery order for the supply of AMOX-CLAV 250-125 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 14, 2024 and is a firm fixed-price contract. This award is not designated as a set-aside contract....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,160.66 firm fixed-price contract is for the delivery of AMOX-CLAV 875-125 MG TABLET 100S medical supplies. The contract has an ultimate completion date of October 5, 2023 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is a delivery order valued at $2,891.52 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 40 units of Amox-Clav ER 1,000-62.5 mg tablets, a prescription medication. The contract has a firm fixed price and an ultimate completion date of January 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,450.00, is for the delivery of Amoxicillin-Clavulanate 500-125 mg tablets in 100-count bottles. The contract is a firm-fixed price type and has a period of performance through March 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Amoxicillin-Clavulanate 875-125 mg tablets in 100-count bottles. The $1,206.01 firm fixed-price contract has an ultimate completion date of August 23, 2024. As a large pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to provide a wide range of essential medical commodities to various government agencies and healthcare programs. The...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,523.78, is for the supply of AMOX-CLAV 875-125 MG TABLET UD 100S and has an ultimate completion date of January 3, 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...